Mergers & Acquisitions

  • April 29, 2026

    Spanish Travel Tech Biz To Buy Biometrics Co. For €1.2B

    Spain's Amadeus said Wednesday it plans to acquire Idemia Public Security, a French biometrics firm, for €1.2 billion ($1.4 billion) as the travel tech giant seeks to boost its border control capabilities.

  • April 28, 2026

    SPAC Targets Maha Capital In $490M Energy-Fintech Deal

    Maha Capital AB, a Swiss public company that boasts a portfolio of energy-related assets and fintech operations, on Tuesday revealed it had entered into a letter of intent to merge with special purpose acquisition company Blue Water Acquisition Corp. IV to form a new, publicly traded company.

  • April 28, 2026

    US, Australian Firms Guide $835M Greenland Rare Earths Deal

    Critical Metals Corp. plans to acquire all outstanding shares of European Lithium Ltd. in an all-stock transaction valued at about $835 million, in a deal that would consolidate ownership of the Greenland rare earths project Tanbreez. 

  • April 28, 2026

    EU Flags Concerns Over Paper Joint Venture

    European enforcers launched an in-depth investigation Tuesday into a planned joint venture between paper manufacturers UPM and Sappi over concerns about the market for magazine paper and several other products.

  • April 28, 2026

    Ex-Exec, Korean Chip Co. Clash Over $2.36M Buyback

    A Korean semiconductor company specializing in memory chips clashed with a former executive in Delaware Chancery Court on Tuesday over whether a $2.36 million stock buyback stripped him of the right to sue before he filed a records request action.

  • April 28, 2026

    Paul Hastings, Gibson Dunn Steer $739M Ligand-Xoma Deal

    Ligand Pharmaceuticals said it plans to purchase XOMA Royalty in a $739 million deal combining the two biotechnology royalty aggregator companies advised by Gibson Dunn & Crutcher LLP and Paul Hastings LLP.

  • April 28, 2026

    Walgreens Can't Use Recording To Undo Investor Claim In Ill.

    An Illinois federal judge has said she won't toss a claim brought by shareholders alleging a former Walgreens president made a false and misleading statement during an investor conference, rejecting the company's argument that an audio recording of that conference warranted a second look at her dismissal ruling.

  • April 28, 2026

    Paramount Seeks FCC OK For Foreign Stakes In WBD Deal

    Paramount has asked for the Federal Communications Commission's blessing for its $110 billion purchase of Warner Bros. Discovery to be completely foreign-owned, even if it only expects actual foreign ownership to come in at just under 50%.

  • April 28, 2026

    Eli Lilly Inks $2.25B AI Genetics Research Pact With Profluent

    AI-focused biotech Profluent said Tuesday it has entered a multiprogram, strategic research collaboration with Eli Lilly and Co. to treat diseases with high unmet need, in a deal that involves an upfront payment and up to $2.25 billion in additional milestone payments. 

  • April 28, 2026

    BMG To Pay Concord PE Owner $1.16B In Music Biz Merger

    BMG said Tuesday it will combine with fellow independent music company Concord in a deal that includes a $1.16 billion payment to Concord's private equity owners, with four law firms advising.

  • April 28, 2026

    $20M Hair Business Sale Dispute Hits Chancery Court

    A medical aesthetics technology company has sued a Korean buyer in the Delaware Chancery Court, accusing it of backing out of a $20 million deal to purchase a hair restoration business after attempting to slash the price at the last minute.

  • April 27, 2026

    GCI Buys Alaskan Fiber Provider For $310M

    One of Alaska's fiber infrastructure providers is coming under new management after GCI Holdings LLC revealed it has entered into a deal worth some $310 million to acquire telecommunications service provider Quintillion.

  • April 27, 2026

    Battery Co. Hit With Investor Action Over 'Phantom Deals'

    Investors in a company that develops artificial intelligence-enhanced rechargeable batteries filed suit on Monday, claiming the company made misleading statements about its partnerships with other companies and its growth prospects, seeking damages for falling stock prices after the truth came to light.

  • April 27, 2026

    Altria, Juul Can Appeal Class Cert. Decision In Antitrust Suit

    The Ninth Circuit on Monday granted Altria and Juul's request to appeal a ruling certifying several classes of e-cigarette buyers in an antitrust case alleging the companies schemed to have Altria exit the e-cigarette market.

  • April 27, 2026

    United CEO Touts Merger Benefits Despite American Rebuff

    United Airlines' chief executive pressed the merits of a mega airline merger Monday, while also confirming recent reports that he had approached American Airlines about exploring a potential combination, and that American shut the door on any such talks.

  • April 27, 2026

    China Blocks Meta's Planned $2B Manus AI Acquisition

    China's top economic planning body on Monday ordered the cancellation of Meta Platforms Inc.'s planned acquisition of Chinese artificial intelligence company Manus.

  • April 27, 2026

    Tech Brokerage Real To Acquire Re/Max In $880M Deal

    Miami-based, technology-focused firm Real Brokerage said Monday that it will acquire Re/Max Holdings in a deal valuing the franchisor at $880 million, with advice from Willkie Farr & Gallagher LLP, Gowling WLG LLP and Morrison Foerster LLP.

  • April 27, 2026

    How A Rush To Trial Paid Off With A Rare FCPA Acquittal

    A defense strategy to fast-track the trial in a yearslong criminal foreign bribery case against a Mexican businessman in Texas appeared to backfire when he was convicted and sent to prison last year, but the gamble ultimately paid off when a judge permanently tossed the case earlier this month.

  • April 27, 2026

    Trump SPAC, Ex-CEO Clash Over $2M In Fees

    A Delaware Chancery Court hearing Monday laid bare a procedural fight over whether a Trump-linked SPAC must immediately pay disputed legal fees to its former CEO or can withhold them while seeking review of a magistrate's ruling.

  • April 27, 2026

    IQVIA Accuses Ex-Execs, Syneos Of Poaching $180M Client

    IQVIA Holdings Inc. is accusing former executives of defecting to a competitor in the clinical research organization industry and initiating a corporate raid that resulted in the loss of one customer worth at least $180 million, according to a lawsuit filed in North Carolina Business Court.

  • April 27, 2026

    AGs Say Live Nation Fix Can't Wait On DOJ Deal Approval

    Live Nation Entertainment Inc. sparred with state attorneys general expected to seek a forced Ticketmaster sale after winning a New York federal jury antitrust verdict, with the company seeking to delay the breakup fight until after the judge reviews a separate U.S. Department of Justice settlement, and the enforcers preferring parallel proceedings.

  • April 27, 2026

    4 Firms Build Astorg's $1.1B Microbiology Biz Buy

    Life sciences company Thermo Fisher Scientific Inc. on Monday announced plans to sell its microbiology business to European private equity firm Astorg in an over $1.1 billion deal steered by four law firms.

  • April 27, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week tackled a fresh mix of deal litigation, procedural disputes and fiduciary duty claims, with several rulings and filings underscoring the court's continued focus on contractual precision, forum enforcement and the limits of stockholder challenges.

  • April 27, 2026

    V&E Expands Corporate Practice With 4 WilmerHale Attys

    Vinson & Elkins LLP announced Monday that it has bolstered its corporate practice with four former WilmerHale attorneys who advise companies and private equity clients in a wide range of corporate and securities matters.

  • April 27, 2026

    Ropes & Gray, Cooley Lead Lilly's $2.3B Cancer Drug Buy

    Eli Lilly and Co. said Monday it will acquire privately held Ajax Therapeutics in a deal worth up to $2.3 billion, as the drugmaker looks to expand its pipeline of treatments for blood cancers.

Expert Analysis

  • Mind The Gap: Crafting D&O Straddle Coverage For M&A

    Author Photo

    A recent Florida federal court decision highlights an often-overlooked risk for those negotiating directors and officers insurance coverage for mergers and acquisitions: the potential for so-called straddle claims, falling in the gap between tail and go-forward coverage, say attorneys at Reed Smith.

  • Calif.'s Civility Push Shows Why Professionalism Is Vital

    Author Photo

    The California Bar’s campaign against discourteous behavior by attorneys, including a newly required annual civility oath, reflects a growing concern among states that professionalism in law needs shoring up — and recognizes that maintaining composure even when stressed is key to both succeeding professionally and maintaining faith in the legal system, says Lucy Wang at Hinshaw.

  • FCC Satellite Co. Action Starts New Chapter For Team Telecom

    Author Photo

    The Federal Communications Commission's recent settlement with satellite company Marlink marks a modest but meaningful step forward in how the U.S. regulates foreign involvement in its telecommunications sector, proving "Team Telecom" conditions are not limited to companies with substantial foreign ownership, says attorney Sohan Dasgupta.

  • Series

    Trivia Competition Makes Me A Better Lawyer

    Author Photo

    Playing trivia taught me to quickly absorb information and recognize when I've learned what I'm expected to know, training me in the crucial skills needed to be a good attorney, and reminding me to be gracious in defeat, says Jonah Knobler at Patterson Belknap.

  • Ruling Puts Guardrails On FTC Merger Filing Rule Expansion

    Author Photo

    A Texas federal court recently vacated the Federal Trade Commission's overhaul of the Hart-Scott-Rodino premerger notification form, in a significant setback for the antitrust agencies, say attorneys at Reed Smith.

  • Series

    Law School's Missed Lessons: What Cross-Selling Truly Takes

    Author Photo

    Early-career attorneys may struggle to introduce clients to practitioners in other specialties, but cross-selling becomes easier once they know why it’s vital to their first years of practice, which mistakes to avoid and how to anticipate clients' needs, say attorneys at Moses & Singer.

  • CFIUS Initiative May Smooth Way For Some Foreign Investors

    Author Photo

    A new program that will allow certain foreign investors to be prevetted and admitted to fast-track approval by the Committee on Foreign Investment in the United States will likely have tangible benefits for investors participating in competitive M&A, say attorneys at Simpson Thacher.

  • Series

    Judges On AI: Practical Use Cases In Chambers

    Author Photo

    U.S. Magistrate Judge Allison Goddard in the Southern District of California discusses how she uses generative artificial intelligence tools in chambers to make work more efficient and effective — from editing jury instructions for clarity to summarizing key documents.

  • Saks' Post-M&A Bankruptcy Illustrates Current Market Risks

    Author Photo

    The recent Saks Fifth Avenue bankruptcy occurred on the heels of its merger with fellow luxury purveyor Neiman Marcus, showing that capital structure, not concept, dictates resilience when conditions turn, says Ben Thompson at Thompson.

  • Series

    Trail Running Makes Me A Better Lawyer

    Author Photo

    Navigating the muddy, root-filled path of trail marathons and ultramarathons provides fertile training ground for my high-stakes fractional general counsel work, teaching me to slow down my mind when the terrain shifts, sharpen my focus and trust my training, says Eric Proos at Next Era Legal.

  • Tips From Del. Decision Nixing Major Earnout Damages Award

    Author Photo

    The Delaware Supreme Court recently vacated in part the largest earnout-related damages award in Delaware history, making clear that the implied covenant of good faith and fair dealing cannot be used to rescue parties from drafting choices where the relevant regulatory risk was foreseeable at signing, say attorneys at Sullivan & Cromwell.

  • CFIUS Risk Lessons From Chips Biz Divestment Order

    Author Photo

    President Donald Trump's January executive order directing HieFo to unwind its 2024 acquisition of a semiconductor business with ties to China underscores that even modestly sized transactions can attract CFIUS interest if they could affect strategic areas prioritized by the U.S. government, say attorneys at Debevoise.

  • Malpractice Claim Assignability Continues To Divide Courts

    Author Photo

    Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.

  • Tips For Counsel As PE Eyes Data Center Facility Services

    Author Photo

    As private equity interest in specialized commercial facility services providers heightens, considerations for counsel and private equity investors run the gamut from contract transferability to facility compliance, say attorneys at Morgan Lewis.

  • Opinion

    CFIUS Must Adapt To Current Foreign Investment Realities

    Author Photo

    To continue protecting the U.S.’ long-term strategic and economic interests, the Committee on Foreign Investment in the United States should implement practical enhancements that leverage technology, expertise and clear communication, and enable it to keep pace with evolving demands, says attorney Sohan Dasgupta.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.